ALK and non-small cell lung carcinoma: And loss of SMARCE1 regulated the expression of epidermal growth factor receptor (EGFR) and resist mesenchymal-to-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitors in NSCLC [18].